AJMB-Avicenna Journal of Medical Biotechnology. 2017; 9 (1): 8-12
en Inglés
| IMEMR
| ID: emr-185806
ABSTRACT
Background:
M2000 is a newly designed and safe Non-Steroidal Anti-Inflammatory Drug [NSAID]. The aim of this study was to assess the effects of M2000 on expression levels of Suppressor of Cytokine Signaling-1 [SOCS-1] and Src Homology-2 domain containing inositol-5'-phosphatase 1 [SHIP1] proteins via Toll-Like Receptor [TLR] 2/microRNA-155 pathway
Buscar en Google
Índice:
IMEMR (Mediterraneo Oriental)
Asunto principal:
Dominios Homologos src
/
MicroARNs
/
Receptor Toll-Like 2
/
Proteína 1 Supresora de la Señalización de Citocinas
/
Irán
Límite:
Humanos
País/Región como asunto:
Asia
Idioma:
Inglés
Revista:
Avicenna J. Med. Biotechnol.
Año:
2017
Similares
MEDLINE
...
LILACS
LIS